George D. Yancopoulos

2013

In 2013, George D. Yancopoulos earned a total compensation of $31M as President, Regeneron Laboratories and Chief Scientific Officer at Regeneron Pharmaceuticals, a 62% decrease compared to previous year.

Compensation breakdown

Bonus$1,759,500
Option Awards$28,096,838
Salary$879,800
Other$281,455
Total$31,017,593

Yancopoulos received $28.1M in option awards, accounting for 90.58% of the total pay in 2013.

Yancopoulos also received $1.8M in bonus, $879.8K in salary and $281.5K in other compensation.

Rankings

In 2013, George D. Yancopoulos' compensation ranked 31st out of 12,164 executive pay records tracked by us. In other words, Yancopoulos earned more than 99.7% of all executives tracked by us in 2013.

ClassificationRankingPercentile
All
31
out of 12,164
100th
Manufacturing
Division
7
out of 4,566
100th
Chemicals And Allied Products
Major group
4
out of 1,418
100th
Drugs
Industry group
3
out of 1,119
100th
Pharmaceutical Preparations
Industry
3
out of 862
100th
Source: SEC filing on April 26, 2016.

Yancopoulos' colleagues

We found five more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2013.

2013

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

2013

Neil Stahl

Regeneron Pharmaceuticals

Executive Vice President, Research & Development

2013

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

2013

Robert Terifay

Regeneron Pharmaceuticals

Executive Vice President, Commercial

2013

Murray Goldberg

Regeneron Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like